MARC Record from Library of Congress

LEADER: 03603cam a2200349 i 4500
001 2015008283
003 DLC
005 20150728083940.0
008 150227s2015 enka b 001 0 eng
010 $a 2015008283
020 $a9781107066007 (pbk.)
020 $a110706600X (pbk.)
035 $a(DNLM)101652849
040 $aDNLM/DLC$cDLC$erda$dDLC
042 $apcc
050 10 $aRC376.5$b.M44 2015
060 10 $aWL 390
082 00 $a616.8/3$223
245 00 $aMedication-induced movement disorders /$cedited by Joseph H. Friedman, Butler Hospital and Department of Neurology at the Alpert Medical School of Brown University, Providence, RI, and School of Pharmacy at the University of Rhode Island, Kingston, RI, USA.
264 1 $aCambridge, United Kingdom :$bCambridge University Press,$c2015.
300 $aix, 197 pages :$billustrations ;$c25 cm
336 $atext$2rdacontent
337 $aunmediated$2rdamedia
338 $avolume$2rdacarrier
504 $aIncludes bibliographical references and index.
505 8 $aMachine generated contents note: List of contributors; Dedication; Introduction; 1. Acute akathisia Drew S. Kern and Anthony E. Lang; 2. Acute dystonia Anne Marthe Meppelink and Mark J. Edwards; 3. Neuroleptic malignant syndrome Atbin Djamashidian and Sean S. O'Sullivan; 4. Serotonin syndrome Dimitrios A. Nacopoulos and Hubert H. Fernandez; 5. Neuroleptic Parkinsonism Joseph H. Friedman; 6. Tardive syndromes Daniel Tarsy and Raminder Parihar; 7. Tardive dyskinesia treatment Tracy M. Jones, Israt Jahan and Theresa A. Zesiewicz; 8. Atypical antipsychotics and movement disorders Rob M. A. de Bie; 9. Restless legs syndrome Roongroj Bhidayasiri and Pattamon Panyakaew; 10. Medication-induced tremors Peter A. Lewitt; 11. L-Dopa dyskinesias Juan Ramirez-Castaneda and Joseph Jankovic; 12. VPA, lithium, amiodarone and other non-DA Michael Silver and Stewart A. Factor; 13. Anti-depressants and movement disorders Gilles Fe;nelon; 14. Ataxia Marina Sanchez Abraham and Oscar S. Gershanik; 15. Myoclonus and asterixis P. D. Thompson, T. J. Kleinig and T. E. Kimber; 16. Imaging in medication-induced Parkinsonism Danna Jennings; 17. Deep brain stimulation for Tardive disorders Bernardo Rodrigues and Kelvin L. Chou; Index.
520 $a"Medications that may produce movement disorders are widely used. The resulting disorders are often highly disconcerting for the patient and their relatives, especially when the connection between medication and disorder is not recognized. However, ascribing an adverse drug effect to medication exposure is often difficult, especially when the side effect is rare. Covering various drugs - including the major classes of medications working primarily on the brain, specifically antipsychotics and antidepressants - this all-encompassing review of medication-induced movement disorders aids early recognition and improved treatment. The problem of what to do when the offending medication cannot be reduced is also reviewed. It discusses the best options for evaluation and treatment, including medical imaging and deep brain stimulation, and guides the clinician in managing the disorder, making this a vital reference for medical specialists and consultants in neurology and neuropharmacology and any clinician seeing patients on medications crossing the blood brain barrier"--Provided by publisher.
650 12 $aMovement Disorders$xetiology.
650 12 $aNeurotoxicity Syndromes$xdiagnosis.
650 22 $aMovement Disorders$xtherapy.
650 22 $aNeurotoxicity Syndromes$xtherapy.
700 1 $aFriedman, Joseph H.,$eeditor.